Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...
In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...
Stanford University School of Medicine–led researchers have found that intensive blood pressure (BP) control produces ...
In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...
Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...
The findings suggest that while intensive BP control can help prevent heart-related complications and reduce deaths, it may ...
Nearly 10% of people live with chronic kidney disease—in other words, their kidneys can't adequately filter waste from their ...
Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.
Maze Therapeutics aims to raise $100 million in an IPO to fund clinical trials for its kidney and related disease treatments.
Professional organizations, support groups, and other resources exist to help you or anyone you know who’s managing CKD. Financial assistance programs are also available to help with treatment ...
India], In a groundbreaking leap for medical science, a revolutionary cell regeneration method is reshaping the treatment of ...